Claims
- 1. A method for the prevention of prostate cancer, which comprises administering to a male warm-blooded animal in need thereof an anti-prostate cancer effective amount of an anti-cancer agent comprising N-[1-methyl-1-(4-methoxyphenyl)ethyl]-3-oxo-4-aza-5α-androst-1-ene-17β-carboxamide or a pharmacologically acceptable salt or ester thereof.
- 2. The method according to claim 1, wherein said anti-prostate cancer agent is administered orally.
- 3. The method according to claim 1, wherein said anti-prostate cancer agent is administered to a human.
- 4. The method according to claim 2, wherein the warm-blooded animal is a human.
Priority Claims (1)
Number |
Date |
Country |
Kind |
9-42335 |
Feb 1997 |
JP |
|
Parent Case Info
This application is a division of application Ser. No. 09/378,800 filed Aug. 23, 1999 (U.S. Pat. No. 6,043,722), which is a continuation-in-part of International Application PCT/JP98/00767 filed Feb. 26, 1998.
US Referenced Citations (5)
Foreign Referenced Citations (4)
Number |
Date |
Country |
0 285 383 A2 |
Oct 1988 |
EP |
0 547 691 A1 |
Jun 1993 |
EP |
8-73492 |
Mar 1996 |
JP |
WO 9200010 |
Jan 1992 |
WO |
Non-Patent Literature Citations (3)
Entry |
CA 117:49007 Preparation of 3-oxo . . . Inhibitors, Kojima et al. (1992). |
Thompson et al, The Prostate, vol 33, pp 217-221 (1997).* |
Brawley et al, European Journal of Cancer., vol 36, pp 1312-1315 (2000). |
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
PCT/JP98/00767 |
Feb 1998 |
US |
Child |
09/378800 |
|
US |